#DNA

Researchers hope to easily identify which colon cancer patients are unlikely to benefit from immune checkpoint inhibitors (ICIs).

There’s big news about metabolism from recent study findings that is shaking up our understanding of how metabolism changes with age.

When physicians include stool-based testing as an option to patients who don’t want colonoscopies, colorectal cancer screening rates go up.

Damon Runyon Cancer Research Foundation Fellows are mapping the genetics of DNA repair, with implications for cancer research.

It is difficult, if not impossible, to imprint on others the what-it’s-likeness of cancer, in my case, brain cancer.

Improved detection methods could make a world of difference for patients undergoing cancer therapy.

I have been incredibly fortunate to be on a medication for six years and nine months with no growth until recently.

Introducing errors in short-lived RNA causes tumors to present antigens on their cell surface, stimulating an immune response.

Researchers analyzed how a combination of cancer treatments and inherited mutations in DNA-repair genes predicted new cancers.

“A customized blood biopsy test has the sensitivity needed to predict which patients are at risk of cancer recurrence.”

Researchers also found that cancer cells may carry dozens or hundreds of copies of the same ring.

In a study, the test proved able to detect and localize more than 20 types of cancer with a high degree of accuracy.

Imagine, taking a simple blood draw to find out if you have cancer, and if so, the cancer’s location and molecular type.

Transforming the more common type A blood into type O could build up blood supplies and reduce shortages around the globe.

They want to find out why the large, long-lived creatures seem to be genetically protected against many cancers.

National Institutes of Health scientists use epigenetics to help predict disease development.